Korro Bio (KRRO) awards SVP 5,500 RSUs vesting through 2028
Rhea-AI Filing Summary
Dolan Oliver reported acquisition or exercise transactions in this Form 4 filing.
Oliver Dolan, Senior Vice President, Finance of Korro Bio, Inc., received a grant of 5,500 shares of common stock issuable upon settlement of restricted stock units on July 15, 2026. These RSUs vest 50% on July 15, 2027 and 50% on July 15, 2028, subject to a continuous Service Relationship. Following this award, he directly holds 23,599 shares, including 16,241 unvested RSU shares scheduled to vest between December 15, 2026 and July 15, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Dolan Oliver
Role
Senior Vice President, Finance
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,500 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 23,599 shares (Direct)
Footnotes (1)
- Represents shares of common stock issuable upon settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan) that will vest as follows: 50% on July 15, 2027 and 50% on July 15, 2028, in each case subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through each such date. Includes 16,241 shares of common stock issuable upon settlement of restricted stock units (RSUs) that remain unvested, consisting of 10,741 shares that will vest on December 15, 2026, 2,750 shares that will vest on July 15, 2027, and 2,750 shares that will vest on July 15, 2028, in each case subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through each such date.
Key Figures
RSU grant shares: 5,500 shares of common stock
Holdings after transaction: 23,599 shares of common stock
Unvested RSU shares: 16,241 shares
+4 more
7 metrics
RSU grant shares
5,500 shares of common stock
Restricted stock units granted on July 15, 2026 under the 2023 Plan
Holdings after transaction
23,599 shares of common stock
Direct holdings of Oliver Dolan following the July 15, 2026 grant
Unvested RSU shares
16,241 shares
Shares issuable upon settlement of RSUs that remain unvested after the grant
RSUs vesting on December 15, 2026
10,741 shares
Portion of unvested RSUs scheduled to vest on December 15, 2026
RSUs vesting July 15, 2027
2,750 shares
Unvested RSUs scheduled to vest on July 15, 2027
RSUs vesting July 15, 2028
2,750 shares
Unvested RSUs scheduled to vest on July 15, 2028
Grant vesting structure
50% / 50%
New 5,500 RSU grant vests 50% on July 15, 2027 and 50% on July 15, 2028
Key Terms
restricted stock unit (RSU), 2023 Stock Option and Incentive Plan, Service Relationship
3 terms
restricted stock unit (RSU) financial
"shares of common stock issuable upon settlement of a restricted stock unit (RSU)"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
2023 Stock Option and Incentive Plan financial
"RSU granted under the Issuer's 2023 Stock Option and Incentive Plan"
Service Relationship financial
"subject to the reporting person maintaining a continuous Service Relationship"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Korro Bio (KRRO) executive Oliver Dolan receive in this insider transaction?
Oliver Dolan received a grant of 5,500 shares of common stock issuable upon settlement of restricted stock units. The RSUs were granted under Korro Bio’s 2023 Stock Option and Incentive Plan and represent part of his equity-based compensation package.
How do the 5,500 RSUs granted to Korro Bio (KRRO) SVP Oliver Dolan vest?
The 5,500 RSUs vest in two equal tranches: 50% on July 15, 2027 and 50% on July 15, 2028. Each tranche vests only if Dolan maintains a continuous Service Relationship with Korro Bio through the respective vesting date.
Under what plan were the new RSUs to Korro Bio (KRRO) SVP Oliver Dolan granted?
The 5,500 RSUs were granted under Korro Bio’s 2023 Stock Option and Incentive Plan. Shares are issuable upon settlement of the units, subject to the vesting schedule and Dolan’s continued Service Relationship with the company.
Is the Korro Bio (KRRO) RSU award to Oliver Dolan contingent on continued employment?
Yes. Each RSU tranche vests only if Oliver Dolan maintains a continuous Service Relationship with Korro Bio through the applicable dates in 2026, 2027, and 2028. If that relationship ends earlier, unvested RSUs may not settle into shares.